Table: Rohto - 6-MTH group results
Nov 10 (Reuters)-
Rohto Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2022 Sep 30, 2021 Mar 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 110.31 91.02 230.00
(+21.2 pct) (+15.2 pct)
Operating 16.27 13.75 31.00
(+18.3 pct) (+6.8 pct)
Recurring 17.96 13.50 32.00
(+33.1 pct) (+11.3 pct)
Net 13.19 11.02 22.00
(+19.7 pct) (+4.1 pct)
EPS 115.65 yen 96.63 yen 96.43 yen
EPS Diluted 115.32 yen 96.35 yen
Ann Div 36.00 yen
-Q2 div 20.00 yen 15.00 yen
-Q4 div 21.00 yen 10.00 yen
NOTE - Rohto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T